TDM Exam Blueprint: Real Weighting and Core Topics
MCC publishes a real blueprint for the TDM exam across two dimensions — how a case is framed, and what kind of intervention it's testing. Here's exactly what MCC's own materials (https://www.mcc.ca/examinations-assessments/tdm-examination/) say, plus a real look at the breadth of topics behind it (https://mcc.ca/core-tdm-examination-topics/).
By Dimensions of Care: Health Promotion & Illness Prevention runs approximately 10–20% of the exam (average 15%), Acute approximately 20–30% (average 25%), Chronic approximately 25–35% (average 30%), and Safety & Adverse Effects approximately 25–35% (average 30%).
By Therapeutic Interventions: Pharmacologic interventions make up approximately 65–75% of the exam (average 70%), and Nonpharmacologic interventions approximately 25–35% (average 30%) — a real, useful signal that TDM leans heavily toward medication-management decisions specifically, not just clinical reasoning in general.
MCC's own core-topics page lists dozens of real named categories spanning the full range of primary-care practice — Cardiovascular (e.g. atrial fibrillation, heart block, myocardial infarction, pericarditis, heart failure), Mental Health (e.g. major depressive disorder, panic disorder, specific phobia, suicidality), Infectious disease (e.g. pneumonia, viral upper respiratory infections, cystitis, pyelonephritis, chlamydia, gonorrhea), and Gastrointestinal & Hepatic (e.g. gastroesophageal reflux disease, inflammatory bowel disease, hemorrhoids) among many others — see MCC's own core-topics page (https://mcc.ca/core-tdm-examination-topics/) for the full exhaustive list rather than a partial summary here.
Study takeaway: given Pharmacologic interventions alone account for roughly 70% of the exam on average, medication-selection and adverse-effect reasoning deserves proportionally more practice time than nonpharmacologic management — and because Chronic and Safety & Adverse Effects together make up the largest share of the Dimensions-of-care split (roughly 60% combined), don't over-index preparation on acute, single-encounter presentations at the expense of ongoing-management and medication-safety scenarios.